Philip D. Cotter active positions
| Companies | Position | Start | End |
|---|---|---|---|
| American College of Medical Genetics & Genomics | Corporate Officer/Principal | 2011-03-28 | - |
| The University of California, San Francisco | Corporate Officer/Principal | 2011-03-28 | - |
ResearchDx, Inc.
 ResearchDx, Inc. Pharmaceuticals: MajorHealth Technology ResearchDx, Inc. is a contract diagnostic organization that offers comprehensive support for clinical trials, including ctdna screening and biomarker discovery and validation services. ResearchDx is based in Irvine, CA and was founded in 2008 by Philip D. Cotter and Mathew W. Moore. The private company provides a range of biopharma services to build, validate, and deliver FDA-approved ivd diagnostic assays through outsourcing to a single partner. The company also offers clinical laboratory consulting services, turnkey clinical laboratory startup services, and preclinical and non-clinical testing. | Founder | 2007-12-31 | - |
| Corporate Officer/Principal | 2007-12-31 | - |
Career history of Philip D. Cotter
Former positions of Philip D. Cotter
| Companies | Position | Start | End |
|---|---|---|---|
| Icahn School of Medicine at Mount Sinai | Corporate Officer/Principal | 1995-12-31 | 1995-12-31 |
Training of Philip D. Cotter
| New York University | Doctorate Degree |
Statistics
International
| United States | 6 |
Operational
| Corporate Officer/Principal | 4 |
| Doctorate Degree | 1 |
| Founder | 1 |
Sectoral
| Consumer Services | 5 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 1 |
|---|---|
ResearchDx, Inc.
ResearchDx, Inc. Pharmaceuticals: MajorHealth Technology ResearchDx, Inc. is a contract diagnostic organization that offers comprehensive support for clinical trials, including ctdna screening and biomarker discovery and validation services. ResearchDx is based in Irvine, CA and was founded in 2008 by Philip D. Cotter and Mathew W. Moore. The private company provides a range of biopharma services to build, validate, and deliver FDA-approved ivd diagnostic assays through outsourcing to a single partner. The company also offers clinical laboratory consulting services, turnkey clinical laboratory startup services, and preclinical and non-clinical testing. | Health Technology |
- Stock Market
- Insiders
- Philip D. Cotter
- Experience
